Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Lilly prepares new benzothiophenes

Nov. 28, 1997

New approvals for Menorest

Nov. 28, 1997

Negative phase II results for long-term risedronate in osteoporosis

Nov. 28, 1997

Launch of Ligand/Lilly metabolic disease alliance

Nov. 27, 1997

Agents activating beta3-adrenoceptors from Pfizer

Nov. 27, 1997

Beaufour-Ipsen moves TH-9506 to phase I

Nov. 27, 1997

First marketing approval granted for Neumega

Nov. 26, 1997

PTK inhibitors for bone disorders from Novartis

Nov. 26, 1997

Roussel Uclaf discloses integrin antagonists for bone disorders

Nov. 26, 1997

ProLease hGH slated to enter phase III

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...